Skip to main content
. 2025 Jun 18;17:1588488. doi: 10.3389/fnagi.2025.1588488

Table 3.

Logistic regression modeling of potential predictors for CI.

Variable Univariable analysis Multivariable analysis
OR (95% CI) p-value OR (95% CI) p-value
Age 1.060 (1.029–1.092) < 0.001* 1.043 (1.009–1.079) 0.014*
Sex 1.292 (0.743–2.249) 0.364
Education 0.901 (0.835–0.972) 0.007* 0.930 (0.854–1.011) 0.089
Body mass index 0.934 (0.866–1.007) 0.075
Current smoking 0.756 (0.391–1.465) 0.408
Alcohol use 0.681 (0.328–1.417) 0.304
Hypertension 1.302 (0.746–2.272) 0.352
SBP 1.013 (0.998–1.027) 0.084
DBP 1.014 (0.991–1.037) 0.240
Diabetes 2.288 (1.256–4.168) 0.007* 1.466 (0.705–3.047) 0.306
Coronary heart disease 1.259 (0.587–2.700) 0.553
History of stroke 1.651 (0.921–2.958) 0.092
Monocyte counts 0.701 (0.256–1.923) 0.491
TC 0.872 (0.679–1.122) 0.287
TG 1.189 (0.805–1.756) 0.385
HDL 0.571 (0.229–1.424) 0.229
LDL 0.789 (0.559–1.113) 0.177
Uric acid 1.000 (0.998–1.002) 0.910
Serum tHcy 1.032 (0.990–1.076) 0.140
FPG 1.261 (1.048–1.517) 0.014* 1.127 (0.908–1.399) 0.278
Severe CSVD burden 4.066 (2.291–7.218) < 0.001* 2.456 (1.306–4.617) 0.005*
MHR 1.632 (1.222–2.180) 0.001* 1.462 (1.057–2.022) 0.022*

*p < 0.05. CI, cognitive impairment; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; TC, total cholesterol; TG, triglyceride; HDL, high density lipoprotein; LDL, low density lipoprotein; tHcy, total homocysteine; MHR, monocyte to high-density lipoprotein cholesterol ratio; CSVD, cerebral small vessel disease.